The Hazard-Perception Study Did Not Measure Blood THC Concentration-Performance Relationships

The medicinal-oil hazard-perception experiment did not collect blood measures that could quantify THC and metabolite concentrations for each condition. Its task findings therefore could not validate a blood concentration-performance relationship.

The investigators identified the missing measurement

The paper explicitly notes that absent blood measures prevented quantification of THC and relevant metabolites and examination of their association with task performance. Oral-fluid screening supplied a different type of information and did not fill this gap.

A prescribed amount is not a concentration

Participants used oils with variable THC doses, strain characteristics and CBD content. A nominal administered amount cannot be substituted for a measured blood concentration. Nor can a screen indication supply the continuous exposure data needed to estimate a concentration-response curve.

Do not borrow a threshold from a task null

The absence of a significant hazard-perception decline does not identify a blood value at which drivers are necessarily unimpaired. The study did not test that proposition. Equally, the missing measurement does not prove concentrations were high, low or unrelated to the outcome. Its contribution concerns video-based performance under the observed use conditions. A forensic concentration opinion needs suitable specimen data and evidence connecting the matrix, sampling time and functional question rather than imputing those measurements to this study.

Related analysis: the study’s main findings and limitations.

Research cited

Mieran and colleagues. The effects of orally ingested Delta-9-Tetrahydrocannabinol on drivers’ hazard perception and risk-taking behaviours: A within-subjects study of medicinal cannabis users. Psychopharmacology. DOI: 10.1007/s00213-025-06869-w.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

A mouse cerebral-malaria experiment summarized in the CBD brain review reported memory findings when CBD was added to artesunate. The observation concerned adjunctive treatment in an infectious-disease model, rather than CBD alone as a general memory enhancer. The disease and co-treatment belonged in the result The review describes CBD treatment…

Spread the love

Read Article: CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Rat experiments summarized in the CBD brain review found different degrees of interference with CBD-related pain responses after serotonin-receptor blockade. The evidence did not establish one exclusive mechanism for every model. The diabetic and nerve-injury models differed In male diabetic rats, the review reports attenuation of mechanical allodynia with CBD…

Spread the love

Read Article: Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

An observational CBD study summarized in the brain-function review reported improvement in pain patients but had substantial participant loss and incomplete dosing information. Those limitations constrained attribution of the change to CBD. The clinical groups did not report one uniform response The review describes Gulbransen and colleagues’ exploratory quality-of-life study….

Spread the love

Read Article: Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us